Vor Ort
Merkzettel Warenkorb
  • Produktbild: Continuous Dopaminergic Stimulation in Parkinson’s Disease
  • Produktbild: Continuous Dopaminergic Stimulation in Parkinson’s Disease
Band 27

Continuous Dopaminergic Stimulation in Parkinson’s Disease Proceedings of the Workshop in Alicante, Spain, September 22–24, 1986

Aus der Reihe Journal of Neural Transmission. Supplementa

49,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

20.05.1988

Abbildungen

XII, 255 p. 52 illus.

Herausgeber

Jose A. Obeso + weitere

Verlag

Springer Wien

Seitenzahl

255

Maße (L/B/H)

27,9/21/1,5 cm

Gewicht

661 g

Sprache

Englisch

ISBN

978-3-211-82034-6

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

20.05.1988

Abbildungen

XII, 255 p. 52 illus.

Herausgeber

Verlag

Springer Wien

Seitenzahl

255

Maße (L/B/H)

27,9/21/1,5 cm

Gewicht

661 g

Sprache

Englisch

ISBN

978-3-211-82034-6

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Continuous Dopaminergic Stimulation in Parkinson’s Disease
  • Produktbild: Continuous Dopaminergic Stimulation in Parkinson’s Disease
  • Continuous dopaminergic stimulation in Parkinson’s disease.- Pathogenetic studies of motor fluctuations in Parkinson’s disease.- The case for and concerns about continuous dopamine stimulation in Parkinson’s disease.- Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson’s disease.- Subcutaneous lisuride infusion in Parkinson’s disease: clinical results using different modes of administration.- Chronic s. c. Lisuride in Parkinson’s disease—motor-performance and avoidance of psychiatric side effects.- Continuous subcutaneous lisuride infusions in Parkinson’s disease.- A combined regimen of subcutaneous lisuride and oral madopar HBS in Parkinson’s disease.- Pharmacokinetics of lisuride after subcutaneous infusion.- Treatment of Parkinson’s disease with subcutaneous lisuride infusions.- Lisuride infusion pump in Parkinson’s disease. A report of two cases.- Discussion.- Complications in treatment.- Psychiatric side effects during the treatment of Parkinson’s disease.- Applications of new drug delivery technologies to Parkinson’s disease and dopaminergic agents.- Discussion.- Continuous dopaminergic stimulation experimental studies.- Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson’s disease.- Receptor changes during chronic dopaminergic stimulation.- Effect of chronic subcutaneous minipump infusion of lisuride upon locomotor activity of rats.- Discussion.- Biochemical basis of diagnostic and therapeutic problems.- Factors contributing to fluctuations of the dopaminergic nigro-striatal feedback system in Parkinson’s disease.- Agonist and antagonist actions of lisuride on dopamine neurons:electrophysiological evidence.- Pharmacokinetic studies with sustained-release formulations of levodopa in healthy volunteers.- Parkinson’s disease and PET tracer studies.- Mapping dopamine receptors in the human brain.- Discussion.- Present state and future developments.- Discussion.- Continuous dopaminergic stimulation: state of the art and outlook.- Listed in Current Contents.